Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ChiCTR-IPR-16009318Phase 4Not yet recruiting
Phase 4, randomised trial in strabismus and Emergence agitation (EA) comparing Group B: butorphanol with Group F: fentanyl (2 arms). Primary endpoints: Incidence of emergence agitation and Postoperative side effects. Planned start Oct 2016; status: not yet recruiting.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on ChiCTR-IPR-16009318.